| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.62B | +24.5% |
| Cost of Revenue | $1.33B | +29.9% |
| Gross Profit | $2.29B | +21.5% |
| R&D Expense | $505.8M | +4.5% |
| SG&A Expense | $1.19B | +18.5% |
| Operating Income | $597.7M | +52.8% |
| Interest Expense | $20.3M | +9.1% |
| Pre-tax Income | $710.4M | +81.8% |
| Income Tax | $168.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $566.3M | -11.8% |
| Accounts Receivable | $973.9M | +36.5% |
| Inventory | $559.6M | +82.5% |
| Current Assets | $4.43B | +20.6% |
| Total Assets | $6.26B | +16.2% |
| Current Liabilities | $1.56B | -15.4% |
| Total Liabilities | $4.20B | +28.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $748.5M | +11.8% |
| Capital Expenditures | $236.6M | -35.1% |
| Investing Cash Flow | -$507.2M | +2.7% |
| Financing Cash Flow | -$318.6M | +42.3% |
| Free Cash Flow | $511.9M | +68.0% |
| +240.5% |
| Net Income | $541.5M | +58.7% |
| EPS (Basic) | $1.40 | +59.1% |
| EPS (Diluted) | $1.30 | +58.5% |
| Stockholders' Equity |
| $2.07B |
| -3.0% |